4D Molecular Therapeutics, Inc. Common Stock
FDMT •
Buy Open
Signal type
Buy
Status
Open
Open Price
$10.88
Stop Loss
$9.16
Performance
-11.21%
Days Open
7
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 8, 2026
Open Price $10.88
Stop Loss $9.16
Timespan Day
Company Profile
Name 4D Molecular Therapeutics, Inc. Common Stock
Ticker FDMT
Market Cap $192.25M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $9.66
List Date Dec 11, 2020
Description
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Website Open Company Website